| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | lysozyme activity | 1.82e-04 | 11 | 37 | 2 | GO:0003796 | |
| GeneOntologyMolecularFunction | coreceptor activity | 3.20e-04 | 72 | 37 | 3 | GO:0015026 | |
| GeneOntologyMolecularFunction | peptidoglycan muralytic activity | 3.46e-04 | 15 | 37 | 2 | GO:0061783 | |
| GeneOntologyBiologicalProcess | adaptive immune response | TRAV9-2 TRAV9-1 TRAV3 SUSD4 CD226 TRAV23DV6 TRAV16 CFHR4 TRAV13-1 | 2.54e-05 | 838 | 40 | 9 | GO:0002250 |
| GeneOntologyBiologicalProcess | regulation of complement activation, alternative pathway | 7.65e-05 | 7 | 40 | 2 | GO:0030451 | |
| GeneOntologyCellularComponent | T cell receptor complex | 7.35e-07 | 163 | 41 | 6 | GO:0042101 | |
| GeneOntologyCellularComponent | collagen type IV trimer | 5.60e-05 | 6 | 41 | 2 | GO:0005587 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 5.79e-05 | 350 | 41 | 6 | GO:0098802 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 6.04e-05 | 519 | 41 | 7 | GO:0009897 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 1.04e-04 | 8 | 41 | 2 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 1.04e-04 | 8 | 41 | 2 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 1.04e-04 | 8 | 41 | 2 | GO:0098645 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | TRAV9-2 TRAV9-1 TRAV3 TRAV23DV6 SCN4A LILRA4 TRAV16 TRAV13-1 | 1.21e-04 | 785 | 41 | 8 | GO:0098797 |
| GeneOntologyCellularComponent | receptor complex | 1.22e-04 | 581 | 41 | 7 | GO:0043235 | |
| GeneOntologyCellularComponent | side of membrane | 2.55e-04 | 875 | 41 | 8 | GO:0098552 | |
| GeneOntologyCellularComponent | complex of collagen trimers | 7.70e-04 | 21 | 41 | 2 | GO:0098644 | |
| GeneOntologyCellularComponent | basement membrane | 1.76e-03 | 122 | 41 | 3 | GO:0005604 | |
| GeneOntologyCellularComponent | cell surface | 5.41e-03 | 1111 | 41 | 7 | GO:0009986 | |
| GeneOntologyCellularComponent | membrane protein complex | TRAV9-2 TRAV9-1 TRAV3 TRAV23DV6 SCN4A LILRA4 TRAV16 TRAV13-1 | 7.77e-03 | 1498 | 41 | 8 | GO:0098796 |
| MousePheno | hematuria | 5.43e-06 | 19 | 26 | 3 | MP:0005161 | |
| MousePheno | abnormal kidney vasculature morphology | 9.38e-06 | 73 | 26 | 4 | MP:0000530 | |
| MousePheno | abnormal renal glomerulus basement membrane morphology | 7.19e-05 | 44 | 26 | 3 | MP:0011348 | |
| MousePheno | abnormal glomerular capillary morphology | 8.77e-05 | 47 | 26 | 3 | MP:0011320 | |
| MousePheno | abnormal kidney capillary morphology | 9.35e-05 | 48 | 26 | 3 | MP:0011310 | |
| MousePheno | decreased skeletal muscle mass | 9.38e-05 | 131 | 26 | 4 | MP:0004819 | |
| MousePheno | abnormal renal glomerulus morphology | 1.10e-04 | 264 | 26 | 5 | MP:0005325 | |
| MousePheno | dilated glomerular capillary | 1.19e-04 | 9 | 26 | 2 | MP:0011509 | |
| MousePheno | abnormal complement protein level | 1.19e-04 | 9 | 26 | 2 | MP:0011566 | |
| MousePheno | uremia | 1.22e-04 | 437 | 26 | 6 | MP:0009644 | |
| MousePheno | myopathy | 1.33e-04 | 54 | 26 | 3 | MP:0000751 | |
| MousePheno | abnormal skeletal muscle mass | 1.54e-04 | 149 | 26 | 4 | MP:0004817 | |
| MousePheno | abnormal renal corpuscle morphology | 1.79e-04 | 293 | 26 | 5 | MP:0002827 | |
| MousePheno | albuminuria | 2.11e-04 | 63 | 26 | 3 | MP:0002871 | |
| MousePheno | abnormal meninges morphology | 2.17e-04 | 12 | 26 | 2 | MP:0005623 | |
| MousePheno | dilated capillary | 2.56e-04 | 13 | 26 | 2 | MP:0020326 | |
| MousePheno | abnormal kidney cortex morphology | 2.86e-04 | 324 | 26 | 5 | MP:0000521 | |
| MousePheno | centrally nucleated skeletal muscle fibers | 4.27e-04 | 80 | 26 | 3 | MP:0009404 | |
| MousePheno | decreased skeletal muscle size | 4.43e-04 | 81 | 26 | 3 | MP:0010240 | |
| MousePheno | abnormal glomerular mesangium morphology | 4.76e-04 | 83 | 26 | 3 | MP:0011339 | |
| MousePheno | abnormal lens capsule morphology | 6.19e-04 | 20 | 26 | 2 | MP:0003236 | |
| MousePheno | abnormal kidney development | 6.63e-04 | 93 | 26 | 3 | MP:0000527 | |
| MousePheno | abnormal capillary morphology | 6.63e-04 | 93 | 26 | 3 | MP:0003658 | |
| MousePheno | abnormal skeletal muscle size | 6.63e-04 | 93 | 26 | 3 | MP:0009458 | |
| MousePheno | delayed kidney development | 6.84e-04 | 21 | 26 | 2 | MP:0000528 | |
| MousePheno | abnormal metanephros morphology | 6.84e-04 | 21 | 26 | 2 | MP:0011364 | |
| MousePheno | abnormal glial cell physiology | 8.68e-04 | 102 | 26 | 3 | MP:0003690 | |
| MousePheno | intracranial hemorrhage | 9.18e-04 | 104 | 26 | 3 | MP:0001915 | |
| MousePheno | increased susceptibility to fungal infection | 9.72e-04 | 25 | 26 | 2 | MP:0005399 | |
| MousePheno | abnormal nephron morphology | 9.94e-04 | 426 | 26 | 5 | MP:0003881 | |
| MousePheno | abnormal renal glomerular capsule morphology | 9.97e-04 | 107 | 26 | 3 | MP:0002828 | |
| MousePheno | abnormal complement pathway | 1.05e-03 | 26 | 26 | 2 | MP:0002471 | |
| MousePheno | abnormal urinary system development | 1.11e-03 | 111 | 26 | 3 | MP:0003942 | |
| MousePheno | abnormal astrocyte physiology | 1.13e-03 | 27 | 26 | 2 | MP:0008916 | |
| MousePheno | impaired muscle relaxation | 1.22e-03 | 28 | 26 | 2 | MP:0003157 | |
| MousePheno | increased mesangial cell number | 1.31e-03 | 29 | 26 | 2 | MP:0011427 | |
| MousePheno | abnormal microglial cell activation | 1.40e-03 | 30 | 26 | 2 | MP:0010762 | |
| MousePheno | decreased renal glomerulus number | 1.40e-03 | 30 | 26 | 2 | MP:0004505 | |
| MousePheno | decreased circulating protein level | 1.48e-03 | 698 | 26 | 6 | MP:0014502 | |
| MousePheno | abnormal susceptibility to fungal infection | 1.50e-03 | 31 | 26 | 2 | MP:0020183 | |
| MousePheno | increased blood urea nitrogen level | 1.87e-03 | 289 | 26 | 4 | MP:0005565 | |
| Domain | CTDL_fold | 1.37e-06 | 107 | 34 | 5 | IPR016187 | |
| Domain | LYZL1/LYZL2 | 3.22e-06 | 2 | 34 | 2 | IPR030057 | |
| Domain | C4 | 4.80e-05 | 6 | 34 | 2 | SM00111 | |
| Domain | - | 4.80e-05 | 6 | 34 | 2 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 4.80e-05 | 6 | 34 | 2 | IPR001442 | |
| Domain | NC1_IV | 4.80e-05 | 6 | 34 | 2 | PS51403 | |
| Domain | C4 | 4.80e-05 | 6 | 34 | 2 | PF01413 | |
| Domain | Glyco_hydro_22_lys | 6.72e-05 | 7 | 34 | 2 | IPR000974 | |
| Domain | Glyco_hydro_22_CS | 6.72e-05 | 7 | 34 | 2 | IPR019799 | |
| Domain | LACTALBUMIN_LYSOZYME_2 | 8.95e-05 | 8 | 34 | 2 | PS51348 | |
| Domain | Lys | 8.95e-05 | 8 | 34 | 2 | PF00062 | |
| Domain | LACTALBUMIN_LYSOZYME_1 | 8.95e-05 | 8 | 34 | 2 | PS00128 | |
| Domain | LYZ1 | 8.95e-05 | 8 | 34 | 2 | SM00263 | |
| Domain | Glyco_hydro_22 | 8.95e-05 | 8 | 34 | 2 | IPR001916 | |
| Domain | Sushi | 1.15e-04 | 52 | 34 | 3 | PF00084 | |
| Domain | CCP | 1.28e-04 | 54 | 34 | 3 | SM00032 | |
| Domain | SUSHI | 1.43e-04 | 56 | 34 | 3 | PS50923 | |
| Domain | Lysozyme-like_dom | 1.43e-04 | 10 | 34 | 2 | IPR023346 | |
| Domain | Sushi_SCR_CCP_dom | 1.51e-04 | 57 | 34 | 3 | IPR000436 | |
| Domain | Ig_2 | 3.14e-04 | 73 | 34 | 3 | PF13895 | |
| Domain | LAMININ_NTER | 3.80e-04 | 16 | 34 | 2 | PS51117 | |
| Domain | Laminin_N | 3.80e-04 | 16 | 34 | 2 | PF00055 | |
| Domain | Laminin_N | 3.80e-04 | 16 | 34 | 2 | IPR008211 | |
| Domain | LamNT | 3.80e-04 | 16 | 34 | 2 | SM00136 | |
| Domain | - | 7.23e-04 | 97 | 34 | 3 | 3.10.100.10 | |
| Domain | C-type_lectin-like/link | 7.67e-04 | 99 | 34 | 3 | IPR016186 | |
| Domain | EGF_LAM_2 | 1.36e-03 | 30 | 34 | 2 | PS50027 | |
| Domain | EGF_LAM_1 | 1.36e-03 | 30 | 34 | 2 | PS01248 | |
| Domain | Laminin_EGF | 1.84e-03 | 35 | 34 | 2 | PF00053 | |
| Domain | EGF_Lam | 1.84e-03 | 35 | 34 | 2 | SM00180 | |
| Domain | Laminin_EGF | 2.17e-03 | 38 | 34 | 2 | IPR002049 | |
| Domain | IG | 6.92e-03 | 421 | 34 | 4 | SM00409 | |
| Domain | Ig_sub | 6.92e-03 | 421 | 34 | 4 | IPR003599 | |
| Domain | - | 7.80e-03 | 73 | 34 | 2 | 2.60.120.260 | |
| Domain | IGc2 | 8.83e-03 | 235 | 34 | 3 | SM00408 | |
| Domain | Ig_sub2 | 8.83e-03 | 235 | 34 | 3 | IPR003598 | |
| Domain | C_TYPE_LECTIN_1 | 9.30e-03 | 80 | 34 | 2 | PS00615 | |
| Domain | Lectin_C | 1.02e-02 | 84 | 34 | 2 | PF00059 | |
| Domain | CLECT | 1.02e-02 | 84 | 34 | 2 | SM00034 | |
| Domain | Collagen | 1.04e-02 | 85 | 34 | 2 | PF01391 | |
| Domain | Collagen | 1.04e-02 | 85 | 34 | 2 | IPR008160 | |
| Domain | C_TYPE_LECTIN_2 | 1.04e-02 | 85 | 34 | 2 | PS50041 | |
| Domain | C-type_lectin-like | 1.07e-02 | 86 | 34 | 2 | IPR001304 | |
| Domain | IG_LIKE | 1.17e-02 | 491 | 34 | 4 | PS50835 | |
| Domain | Galactose-bd-like | 1.27e-02 | 94 | 34 | 2 | IPR008979 | |
| Domain | Ig-like_dom | 1.27e-02 | 503 | 34 | 4 | IPR007110 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.75e-05 | 30 | 28 | 3 | M27216 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 8.21e-05 | 43 | 28 | 3 | M53 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 1.70e-04 | 10 | 28 | 2 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 1.70e-04 | 10 | 28 | 2 | MM1560 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 2.07e-04 | 11 | 28 | 2 | M15422 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 2.12e-04 | 59 | 28 | 3 | M27218 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 2.48e-04 | 12 | 28 | 2 | MM1526 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 2.93e-04 | 13 | 28 | 2 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 2.93e-04 | 13 | 28 | 2 | M12950 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 2.95e-04 | 66 | 28 | 3 | M18 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 3.41e-04 | 14 | 28 | 2 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 3.41e-04 | 14 | 28 | 2 | M6487 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 3.93e-04 | 15 | 28 | 2 | M27161 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 3.93e-04 | 15 | 28 | 2 | MM14922 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 4.48e-04 | 76 | 28 | 3 | M27219 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 5.71e-04 | 18 | 28 | 2 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 5.71e-04 | 18 | 28 | 2 | MM14882 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 7.07e-04 | 20 | 28 | 2 | M15394 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 7.07e-04 | 20 | 28 | 2 | MM15061 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 8.86e-04 | 96 | 28 | 3 | M39834 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 9.38e-04 | 23 | 28 | 2 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 9.38e-04 | 23 | 28 | 2 | MM1427 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.82e-03 | 32 | 28 | 2 | MM14924 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 2.56e-03 | 38 | 28 | 2 | MM14969 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 2.62e-03 | 140 | 28 | 3 | M587 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 2.97e-03 | 41 | 28 | 2 | MM15538 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 3.12e-03 | 42 | 28 | 2 | M7169 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 3.27e-03 | 43 | 28 | 2 | M39565 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 3.42e-03 | 44 | 28 | 2 | M27812 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 3.73e-03 | 46 | 28 | 2 | M198 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 4.39e-03 | 50 | 28 | 2 | MM14796 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 4.92e-03 | 53 | 28 | 2 | MM14566 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 5.00e-03 | 575 | 28 | 5 | M29853 | |
| Pubmed | 7.38e-09 | 124 | 41 | 6 | 8188290 | ||
| Pubmed | 1.27e-07 | 9 | 41 | 3 | 8562707 | ||
| Pubmed | 2.49e-07 | 11 | 41 | 3 | 14998921 | ||
| Pubmed | 3.32e-07 | 12 | 41 | 3 | 16024816 | ||
| Pubmed | Basal lamina molecules are concentrated in myogenic regions of the mouse limb bud. | 4.31e-07 | 13 | 41 | 3 | 9833687 | |
| Pubmed | 6.85e-07 | 15 | 41 | 3 | 10625553 | ||
| Pubmed | 6.85e-07 | 15 | 41 | 3 | 9264260 | ||
| Pubmed | 8.42e-07 | 16 | 41 | 3 | 15878328 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 15583824 | ||
| Pubmed | Laminin γ-1 and collagen α-1 (VI) chain are galactose-α-1,3-galactose-bound allergens in beef. | 1.36e-06 | 2 | 41 | 2 | 24180678 | |
| Pubmed | 3.88e-06 | 26 | 41 | 3 | 24742657 | ||
| Pubmed | Identification of an Altered Matrix Signature in Kidney Aging and Disease. | 4.06e-06 | 3 | 41 | 2 | 34049963 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 6386565 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 30578652 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 8153091 | ||
| Pubmed | 5.44e-06 | 29 | 41 | 3 | 22613833 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 27619726 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 26490262 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 11827796 | ||
| Pubmed | Large-scale identification of genes implicated in kidney glomerulus development and function. | 8.87e-06 | 34 | 41 | 3 | 16498405 | |
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 8359228 | ||
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 7516699 | ||
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 2071146 | ||
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 10783260 | ||
| Pubmed | 1.46e-05 | 40 | 41 | 3 | 27068110 | ||
| Pubmed | Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. | 2.03e-05 | 6 | 41 | 2 | 10534397 | |
| Pubmed | Stimulation of extracellular matrix components in the normal brain by invading glioma cells. | 2.03e-05 | 6 | 41 | 2 | 9506531 | |
| Pubmed | 2.03e-05 | 6 | 41 | 2 | 7495302 | ||
| Pubmed | A tumor derived motility factor that stimulates cell migration on extracellular matrix. | 2.03e-05 | 6 | 41 | 2 | 9673377 | |
| Pubmed | Nidogen-2: a new basement membrane protein with diverse binding properties. | 2.03e-05 | 6 | 41 | 2 | 9733643 | |
| Pubmed | 2.03e-05 | 6 | 41 | 2 | 2426947 | ||
| Pubmed | Angiogenesis and collagen type IV expression in different endothelial cell culture systems. | 2.03e-05 | 6 | 41 | 2 | 23551189 | |
| Pubmed | Monoclonal antibody to human basement membrane collagen type IV. | 2.03e-05 | 6 | 41 | 2 | 6811420 | |
| Pubmed | 2.03e-05 | 6 | 41 | 2 | 11732842 | ||
| Pubmed | Developmental distribution of collagen IV isoforms and relevance to ocular diseases. | 2.03e-05 | 6 | 41 | 2 | 19275937 | |
| Pubmed | 2.03e-05 | 6 | 41 | 2 | 6988303 | ||
| Pubmed | Immunolocalization of collagen types, laminin and fibronectin in the normal human pancreas. | 2.03e-05 | 6 | 41 | 2 | 6389236 | |
| Pubmed | 2.03e-05 | 6 | 41 | 2 | 12225806 | ||
| Pubmed | 2.03e-05 | 6 | 41 | 2 | 29563520 | ||
| Pubmed | Premature aggregation of type IV collagen and early lethality in lysyl hydroxylase 3 null mice. | 2.84e-05 | 7 | 41 | 2 | 15377789 | |
| Pubmed | 2.84e-05 | 7 | 41 | 2 | 10639489 | ||
| Pubmed | 2.84e-05 | 7 | 41 | 2 | 7521231 | ||
| Pubmed | 2.84e-05 | 7 | 41 | 2 | 11711546 | ||
| Pubmed | Regulation of protease nexin-1 target protease specificity by collagen type IV. | 2.84e-05 | 7 | 41 | 2 | 8006028 | |
| Pubmed | 2.84e-05 | 7 | 41 | 2 | 22535408 | ||
| Pubmed | 2.84e-05 | 7 | 41 | 2 | 17418794 | ||
| Pubmed | 2.84e-05 | 7 | 41 | 2 | 10416788 | ||
| Pubmed | 2.84e-05 | 7 | 41 | 2 | 18006695 | ||
| Pubmed | Hypoplastic basement membrane of the lens anlage in the inheritable lens aplastic mouse (lap mouse). | 2.84e-05 | 7 | 41 | 2 | 10716744 | |
| Pubmed | 2.84e-05 | 7 | 41 | 2 | 1724753 | ||
| Pubmed | Extracellular-matrix gene expression during mouse submandibular gland development. | 3.78e-05 | 8 | 41 | 2 | 9382709 | |
| Pubmed | 3.78e-05 | 8 | 41 | 2 | 12945048 | ||
| Pubmed | 3.78e-05 | 8 | 41 | 2 | 8812145 | ||
| Pubmed | 3.78e-05 | 8 | 41 | 2 | 8725284 | ||
| Pubmed | Linkage of genes for laminin B1 and B2 subunits on chromosome 1 in mouse. | 3.78e-05 | 8 | 41 | 2 | 2993224 | |
| Pubmed | 3.78e-05 | 8 | 41 | 2 | 10382266 | ||
| Pubmed | 3.78e-05 | 8 | 41 | 2 | 11683410 | ||
| Pubmed | 3.78e-05 | 8 | 41 | 2 | 3997552 | ||
| Pubmed | Type IV collagen α6 chain is a regulator of keratin 10 in keratinization of oral mucosal epithelium. | 3.78e-05 | 8 | 41 | 2 | 29422532 | |
| Pubmed | Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons. | 3.78e-05 | 8 | 41 | 2 | 10970885 | |
| Pubmed | 3.78e-05 | 8 | 41 | 2 | 10508765 | ||
| Pubmed | 3.78e-05 | 8 | 41 | 2 | 1383086 | ||
| Pubmed | 3.78e-05 | 8 | 41 | 2 | 1377218 | ||
| Pubmed | New genetic associations detected in a host response study to hepatitis B vaccine. | 4.55e-05 | 824 | 41 | 7 | 20237496 | |
| Pubmed | 4.86e-05 | 9 | 41 | 2 | 9878537 | ||
| Pubmed | 4.86e-05 | 9 | 41 | 2 | 15102706 | ||
| Pubmed | 4.86e-05 | 9 | 41 | 2 | 12101409 | ||
| Pubmed | 6.07e-05 | 10 | 41 | 2 | 23610400 | ||
| Pubmed | 6.07e-05 | 10 | 41 | 2 | 3384439 | ||
| Pubmed | 6.07e-05 | 10 | 41 | 2 | 9136074 | ||
| Pubmed | Generation of a conditionally null allele of the laminin alpha1 gene. | 6.07e-05 | 10 | 41 | 2 | 16100707 | |
| Pubmed | 6.07e-05 | 10 | 41 | 2 | 9415455 | ||
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 7.41e-05 | 11 | 41 | 2 | 7500359 | |
| Pubmed | Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. | 7.41e-05 | 11 | 41 | 2 | 9731539 | |
| Pubmed | 8.88e-05 | 12 | 41 | 2 | 8918877 | ||
| Pubmed | Basement membrane fragility underlies embryonic lethality in fukutin-null mice. | 8.88e-05 | 12 | 41 | 2 | 15837576 | |
| Pubmed | Matrilin-2 interacts with itself and with other extracellular matrix proteins. | 8.88e-05 | 12 | 41 | 2 | 12180907 | |
| Pubmed | 1.05e-04 | 13 | 41 | 2 | 36350252 | ||
| Pubmed | ECM-integrin signalling instructs cellular position sensing to pattern the early mouse embryo. | 1.05e-04 | 13 | 41 | 2 | 34908109 | |
| Pubmed | Basement membranes in skin are differently affected by lack of nidogen 1 and 2. | 1.05e-04 | 13 | 41 | 2 | 18356808 | |
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 1.13e-04 | 79 | 41 | 3 | 18757743 | |
| Pubmed | 1.22e-04 | 14 | 41 | 2 | 12878203 | ||
| Pubmed | 1.22e-04 | 14 | 41 | 2 | 19858219 | ||
| Pubmed | Inhibition of distal lung morphogenesis in Nkx2.1(-/-) embryos. | 1.41e-04 | 15 | 41 | 2 | 10706142 | |
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 1.41e-04 | 15 | 41 | 2 | 15895400 | |
| Pubmed | 1.41e-04 | 15 | 41 | 2 | 38103869 | ||
| Pubmed | 1.61e-04 | 16 | 41 | 2 | 16880404 | ||
| Pubmed | A mouse knockout library for secreted and transmembrane proteins. | 2.00e-04 | 460 | 41 | 5 | 20562862 | |
| Pubmed | Hemidesmosome integrity protects the colon against colitis and colorectal cancer. | 2.05e-04 | 18 | 41 | 2 | 27371534 | |
| Pubmed | 2.05e-04 | 18 | 41 | 2 | 12571105 | ||
| Pubmed | ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells. | 2.05e-04 | 18 | 41 | 2 | 39040056 | |
| Pubmed | 2.05e-04 | 18 | 41 | 2 | 9160753 | ||
| Pubmed | 2.17e-04 | 251 | 41 | 4 | 28077445 | ||
| Pubmed | 2.29e-04 | 19 | 41 | 2 | 15689378 | ||
| Pubmed | 2.55e-04 | 104 | 41 | 3 | 9205841 | ||
| Pubmed | 2.81e-04 | 21 | 41 | 2 | 23325811 | ||
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 4.33e-04 | 26 | 41 | 2 | 34189436 | |
| Pubmed | 4.67e-04 | 27 | 41 | 2 | 2574151 | ||
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 5.01e-04 | 313 | 41 | 4 | 38270169 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 5.47e-04 | 135 | 41 | 3 | 28675934 | |
| Interaction | MAN2A2 interactions | 1.57e-05 | 93 | 33 | 4 | int:MAN2A2 | |
| Cytoband | 14q11 | 2.09e-09 | 132 | 41 | 6 | 14q11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q11 | 4.97e-07 | 332 | 41 | 6 | chr14q11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12p13 | 3.87e-03 | 353 | 41 | 3 | chr12p13 | |
| GeneFamily | T-cell receptor alpha locus at 14q11.2 | 1.27e-07 | 117 | 37 | 6 | 371 | |
| GeneFamily | Lysozymes, c-type | 1.45e-04 | 9 | 37 | 2 | 1174 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 2.14e-04 | 57 | 37 | 3 | 1179 | |
| GeneFamily | Collagens | 3.99e-03 | 46 | 37 | 2 | 490 | |
| GeneFamily | C-type lectin domain family | 4.16e-03 | 47 | 37 | 2 | 494 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 8.32e-03 | 394 | 37 | 4 | 471 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 3.68e-07 | 40 | 39 | 4 | M5887 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 5.28e-06 | 23 | 39 | 3 | M48001 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_T-T_NK-CD8_T_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.22e-07 | 189 | 41 | 5 | 347dea83d0c612341c1ef6e5df5e369520f0a0a4 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_T|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.44e-07 | 190 | 41 | 5 | 04e765ecd42dfcde0891b13733854489b1c79fbc | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_T-T_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.44e-07 | 190 | 41 | 5 | e58c52981bea616a93c3dac4418081d3a8827e60 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_T-T_NK-Treg|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.44e-07 | 190 | 41 | 5 | 8540f4dee99280109e38b997d9247b176808c51a | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_T-T_NK-CD4_T_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.12e-07 | 193 | 41 | 5 | 031fbc9723b0ffd50e1d5362822610429ee60e08 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_T-T_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.84e-07 | 196 | 41 | 5 | cd23c6a29ead3f3ec23c871e6e30bb8812bf1973 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_T|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.84e-07 | 196 | 41 | 5 | 6fb93466e53a12f8292da29b9e4952d453b913c3 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-T-T_CD4-CD4|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.01e-06 | 197 | 41 | 5 | 4bc76958ca12af2dd490d4865de6a92554a14656 | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-T-T_CD4-CD4_TRM/EMRA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.03e-06 | 198 | 41 | 5 | 516b48b298a6719a4b4a1973271d140538598f95 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-T-T_CD4|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.03e-06 | 198 | 41 | 5 | 8d86b5c875d4663ea4d61f50a4eaff1883d97641 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-T-T_CD8-CD8_TRM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.09e-06 | 200 | 41 | 5 | 117c8154375b137e8e4453f294c083a0973a97d5 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_T-T_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.09e-06 | 200 | 41 | 5 | b7ab3f644e6002635771dccaa192a111b4e0ed5b | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_T|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.09e-06 | 200 | 41 | 5 | 2e01a35caeff5967a8b873c5122500d068dcf54c | |
| ToppCell | Adult-Immune-dendritic_cell|Adult / Lineage, Cell type, age group and donor | 1.59e-05 | 165 | 41 | 4 | 073f52698dac1fe4edd7410865f81b30e1c7196a | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_T-T_NK-CD8_T_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.24e-05 | 180 | 41 | 4 | 5273aa2b939b5c640d708d6ca1812550dff5ec0f | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_T-T_NK-NK_T_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.59e-05 | 187 | 41 | 4 | 3301e0fca8c436d136c71f1a8fd59b3bb11bdd83 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.65e-05 | 188 | 41 | 4 | 8268574584e5fb869a6cb8bbd7135cd7454a6a25 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_T-T_NK-CD4_T_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.65e-05 | 188 | 41 | 4 | ce58cd026bfe3fed685a13be47075de2ddb93e36 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_T-T_NK-CD4_T_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.76e-05 | 190 | 41 | 4 | 8fdf35c2ad1d325c00c00e4fcf2506341ff14537 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.76e-05 | 190 | 41 | 4 | 59720dfe9de1b980807644536c919d2a02ba69dd | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.76e-05 | 190 | 41 | 4 | 423b54c6d48d6981a9522043252239303dccaf04 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.76e-05 | 190 | 41 | 4 | 81e7d4f97b958b4ed14298a77104ef31a6ec6c91 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.76e-05 | 190 | 41 | 4 | a1b19028c36d192352bc8a7f187790f4b56cfe17 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-T_&_ILC-Treg|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.76e-05 | 190 | 41 | 4 | fe6fecdf2123f3a4fb20e7535472d562b1a74fb4 | |
| ToppCell | control-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.94e-05 | 193 | 41 | 4 | 89d407a88b5956559a589425b89b3eb8dc78e1dd | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_T|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.00e-05 | 194 | 41 | 4 | 4abc925820d23793d6ebf83fd7df8e75b32f09b4 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_T-T_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.00e-05 | 194 | 41 | 4 | b1ed9b7ea9298dc3ce900a2c6b0a2ca6412f1f5f | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-T-T_CD4-CD4_TRM/EMRA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.06e-05 | 195 | 41 | 4 | 6b6c4a0c713f32c757bd303aa84ec7dc3d825cc8 | |
| ToppCell | critical-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.12e-05 | 196 | 41 | 4 | c861f017aa9050282aa81c5a445bae399df00e4f | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.37e-05 | 200 | 41 | 4 | ca5401b76ab014080914bf78042d368cf318effa | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.37e-05 | 200 | 41 | 4 | 40286010bd17cf9e34ecd5440953b072ebfae208 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1--L2-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.37e-05 | 200 | 41 | 4 | 70c47d3bbe67d88c5b9dff99c33a603d25fa2ab0 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Parm1|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.46e-04 | 111 | 41 | 3 | 1847dde68d349114286bc3317be6339666df4aa2 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_ALM_Slco2a1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.48e-04 | 133 | 41 | 3 | 9d7a08170d38ae9b2ff10a0fa505aeb3aae2824d | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.53e-04 | 134 | 41 | 3 | cb676d5bbc468bd3ce1b6712d41c986ee9221ac5 | |
| ToppCell | COVID-19_Mild-Neu_0|World / 5 Neutrophil clusters in COVID-19 patients | 2.88e-04 | 140 | 41 | 3 | 93f024473b1bb3bf93ae776fd6a8fc5e93d013f0 | |
| ToppCell | tumor_Lung-T/NK_cells-CD8_low_T|T/NK_cells / Location, Cell class and cell subclass | 3.01e-04 | 142 | 41 | 3 | eaf08a0dbacc9ebbd54e377922e76d8ba854dcb8 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.01e-04 | 142 | 41 | 3 | 7b6678a73d04feac12bbc909f2df478215511de0 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.01e-04 | 142 | 41 | 3 | 347f5832a86f4e41752e36e3e737df7ca6f79e90 | |
| ToppCell | facs-Trachea-3m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.13e-04 | 144 | 41 | 3 | 8bd042f12186f36bc5aabf6a0232270a448f4b58 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD56bright|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.60e-04 | 151 | 41 | 3 | 535872e231ac0ee7b4fc4d02a260752cbbf50a2b | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.60e-04 | 151 | 41 | 3 | 512f7f37ddc8dfa1906f7fff92b571929236c9ea | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.74e-04 | 153 | 41 | 3 | e7d20c88466ff81db613869cf7a6a4bb95fd6c2f | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.74e-04 | 153 | 41 | 3 | ce7a23c687e9e7d83d244046de19c854caded09b | |
| ToppCell | COVID-19_Moderate-MAIT|World / disease group, cell group and cell class | 4.26e-04 | 160 | 41 | 3 | bf73c5fe87c1f243edec17d7a2c30fae5e2cfd6b | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-CD4-positive,_alpha-beta_T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.34e-04 | 161 | 41 | 3 | e8f6cac9519a271ec1227338216d9757def99dcb | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-04 | 162 | 41 | 3 | 5731f9514434296132df4bc86f78ce87b07cdeca | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-04 | 162 | 41 | 3 | 0321fc954ae4ad67ca438cbbc84632562d222188 | |
| ToppCell | AT1-AT2_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 4.42e-04 | 162 | 41 | 3 | 57d627259d27f39885bf416d74bcb6656db6e27b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.58e-04 | 164 | 41 | 3 | 8f3255d7f67890389a768453492243ea982eb38a | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_NK-T_NK-NK_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.74e-04 | 166 | 41 | 3 | 05d3e7f441089d788a192d7fa1ec5c302d1ca202 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-Th1|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.83e-04 | 167 | 41 | 3 | 9c55ec8f70b86d4d3d5c2a6ecd9bff2dafe68c11 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.83e-04 | 167 | 41 | 3 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | facs-Marrow-KLS-24m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-04 | 169 | 41 | 3 | d6ad3b637de2935c656aad47ad82d6e8a8bd1227 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-04 | 169 | 41 | 3 | 0f5e737b265ba333275a0cd289dab029a1542075 | |
| ToppCell | facs-Marrow-KLS-24m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-04 | 169 | 41 | 3 | 60ef186518d0dc63dbded2a77c65cfe3129df754 | |
| ToppCell | TCGA-Prostate-Solid_Tissue_Normal-Prostate_normal_tissue-Prostate_normal_tissue-4|TCGA-Prostate / Sample_Type by Project: Shred V9 | 5.17e-04 | 171 | 41 | 3 | cafcb7714110cb361808dbe4b9a4963bb71f5129 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.17e-04 | 171 | 41 | 3 | 3d60e7ecf25e4b781ba2387671b2aad247fb75ff | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 5.44e-04 | 174 | 41 | 3 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | TCGA-Prostate-Solid_Tissue_Normal-Prostate_normal_tissue-Prostate_normal_tissue|TCGA-Prostate / Sample_Type by Project: Shred V9 | 5.44e-04 | 174 | 41 | 3 | de6c1ebca36ec8060ddcafc270c45d6ab1caec2c | |
| ToppCell | TCGA-Prostate-Solid_Tissue_Normal|TCGA-Prostate / Sample_Type by Project: Shred V9 | 5.44e-04 | 174 | 41 | 3 | abdb5a89118b82bb64469fc41c163bd2b282b0c0 | |
| ToppCell | TCGA-Prostate-Solid_Tissue_Normal-Prostate_normal_tissue|TCGA-Prostate / Sample_Type by Project: Shred V9 | 5.44e-04 | 174 | 41 | 3 | 0dde0e9ef987c52cb29a238f15568a83424d02f6 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.53e-04 | 175 | 41 | 3 | 96219e58dcb327fd27190be78193e7a0d611e62b | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.53e-04 | 175 | 41 | 3 | cb974fbebe8cb58c7d3f7defabb4e056f2fee5fa | |
| ToppCell | droplet-Bladder-nan-24m-Hematologic-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.62e-04 | 176 | 41 | 3 | 0089b50d607f4d2f18639fab0f3fc779227baa7a | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.72e-04 | 177 | 41 | 3 | 59cf56c385c324f0844f20003d2b5049a2791e45 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.72e-04 | 177 | 41 | 3 | 2f81b26be89cc2fd8eafadaf7eae3c6ad6521462 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_memory_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.72e-04 | 177 | 41 | 3 | 47813ad05527ea583e736b54b7a48f7ad90c3aef | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_T-T_NK-NK_T_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.81e-04 | 178 | 41 | 3 | a34bb693b72684cbd97ac9efff77d2d14e41be75 | |
| ToppCell | control-NK_CD56bright|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.81e-04 | 178 | 41 | 3 | f3d0bc9a39ed94785676f10c285c5b031bc93aae | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-MAIT_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.81e-04 | 178 | 41 | 3 | 0290868dc990878eac5c182fe64968333bc52450 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-gdT|Multiple_Sclerosis / Disease, Lineage and Cell Type | 5.91e-04 | 179 | 41 | 3 | ab8d8104b38603ec7fbc5b35d7149e71ad57c43a | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_10|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.00e-04 | 180 | 41 | 3 | 32d871738a24071b70084a7e80148a516110c78b | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.00e-04 | 180 | 41 | 3 | 455d1e3ccf2ab609954f3b870e8f514ddca735f4 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_10|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.00e-04 | 180 | 41 | 3 | 067ca8a15228c7f3b3bc7aecbc9b1611ca05e176 | |
| ToppCell | facs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.10e-04 | 181 | 41 | 3 | cc77ac0e223e012767222e45c5dcadc246d1aa7c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_FOS|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.10e-04 | 181 | 41 | 3 | 46c428037b6eac605635e20e8cc78bce744b4daa | |
| ToppCell | facs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.10e-04 | 181 | 41 | 3 | b0fff0defba9aea6fba36e378b05a59986e2573a | |
| ToppCell | facs-Lung-18m-Endothelial-lymphatic_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.10e-04 | 181 | 41 | 3 | ecd52f33841f4e9d946a4edad0d58da9b0cc5ffa | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.20e-04 | 182 | 41 | 3 | e1e58176f533092b6b974ca1ce8b02192a6e193d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.20e-04 | 182 | 41 | 3 | 4a9c13932e7163fd37a3dcc4c6ca3bbea5372459 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.20e-04 | 182 | 41 | 3 | 57bb5a2da976464ba7c4460106bd9f692008ebd9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.30e-04 | 183 | 41 | 3 | f8b636391f752e379a5c5575fd898bdf0907a3b8 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-1|TCGA-Skin / Sample_Type by Project: Shred V9 | 6.30e-04 | 183 | 41 | 3 | cd00e2cd901df4b3f5f7aed747cc0b47f6d3c811 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|bone_marrow / Manually curated celltypes from each tissue | 6.30e-04 | 183 | 41 | 3 | 37db007cc65005bffc18a5fda7f454a57c9fb0a9 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo|bone_marrow / Manually curated celltypes from each tissue | 6.30e-04 | 183 | 41 | 3 | 2fb78622adc170dd3301e251418337523de50faf | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.40e-04 | 184 | 41 | 3 | e2de27cee3ea80f9b7a9a7884ceceeaa67b3214a | |
| ToppCell | NS-moderate-d_07-13-Myeloid-Neutrophil|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.40e-04 | 184 | 41 | 3 | 4c7d05f1a4556b13cedbaaf88d67ac32d09b109b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.40e-04 | 184 | 41 | 3 | ae0a77e3e520a246b17776bb19503519636b02ee | |
| ToppCell | Control-T_cells-NK_cells|Control / group, cell type (main and fine annotations) | 6.50e-04 | 185 | 41 | 3 | 755c0998c729f462399f1d5e88adf4bfae31be30 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic_-_developing-DN1_thymic_pro-T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.50e-04 | 185 | 41 | 3 | 5db31631a4b4c4bfeb28f02d8dab00a48d77bcba | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 6.60e-04 | 186 | 41 | 3 | e93415b59dd89bc8a966dab0e0b65fe215933598 | |
| ToppCell | Mild-Lymphoid-T-NK|Mild / Condition, Lineage, Cell class and cell subclass | 6.60e-04 | 186 | 41 | 3 | ed37a2df547661d22c1ed0b30cb1c19e489d9d0a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.60e-04 | 186 | 41 | 3 | a417e1e21313a7e05951038cdef5ac672a9f727c | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.60e-04 | 186 | 41 | 3 | 080e56113b89138277a2bd2eabddfa6cd1a18b61 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-Treg|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.60e-04 | 186 | 41 | 3 | 2a9daf96c2a47f1ed5421130f32f17bd33e644a7 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_T-T_NK-NK_T_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.60e-04 | 186 | 41 | 3 | b099cb0902e9afb11218d70407d3cab212343c6d | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.60e-04 | 186 | 41 | 3 | dae6a98963c78bf7518ebab8dc02f173c3b0f7f7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.60e-04 | 186 | 41 | 3 | 77592a6397b44b2b59a4fc39d7224dd95343efe6 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-stromal_related-T_reticular|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.71e-04 | 187 | 41 | 3 | f0c4d93f75615e570e4465fd622e3124189618a1 | |
| Drug | Propoxycaine hydrochloride [550-83-4]; Up 200; 12uM; MCF7; HT_HG-U133A | 1.24e-05 | 198 | 35 | 5 | 3583_UP | |
| Drug | 1,6-anhydromuramic acid | 2.29e-05 | 5 | 35 | 2 | CID005492540 | |
| Drug | muramic lactam | 3.43e-05 | 6 | 35 | 2 | CID000161874 | |
| Drug | C-MBT | 3.43e-05 | 6 | 35 | 2 | CID002723842 | |
| Drug | 5-mercaptouridine monophosphate | 3.43e-05 | 6 | 35 | 2 | CID003081517 | |
| Drug | potassium selenate | 6.39e-05 | 8 | 35 | 2 | CID000062680 | |
| Drug | RAWVAWRNR | 8.21e-05 | 9 | 35 | 2 | CID000460901 | |
| Drug | triamterene | 9.69e-05 | 58 | 35 | 3 | CID000005546 | |
| Drug | Dimethisoquin hydrochloride [2773-92-4]; Up 200; 13uM; PC3; HT_HG-U133A | 1.89e-04 | 187 | 35 | 4 | 4207_UP | |
| Drug | 17-AAG; Up 200; 1uM; PC3; HT_HG-U133A | 1.97e-04 | 189 | 35 | 4 | 4430_UP | |
| Drug | Fludrocortisone acetate [514-36-3]; Down 200; 9.4uM; PC3; HT_HG-U133A | 2.09e-04 | 192 | 35 | 4 | 4342_DN | |
| Drug | Glimepiride [93479-97-1]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 2.13e-04 | 193 | 35 | 4 | 4973_DN | |
| Drug | chlorpromazine hydrochloride; Up 200; 1uM; HL60; HT_HG-U133A | 2.22e-04 | 195 | 35 | 4 | 6176_UP | |
| Drug | Aminopurine, 6-benzyl [1214-39-7]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 2.22e-04 | 195 | 35 | 4 | 2313_DN | |
| Drug | Corticosterone [50-22-6]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 2.22e-04 | 195 | 35 | 4 | 4145_DN | |
| Drug | Karakoline [39089-30-0]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 2.22e-04 | 195 | 35 | 4 | 4763_UP | |
| Drug | Iodipamide [606-17-7]; Up 200; 3.6uM; MCF7; HT_HG-U133A | 2.26e-04 | 196 | 35 | 4 | 5510_UP | |
| Drug | Orphenadrine hydrochloride [341-69-5]; Down 200; 13uM; MCF7; HT_HG-U133A | 2.26e-04 | 196 | 35 | 4 | 2318_DN | |
| Drug | cox-2 inhibitor I; Down 200; 10uM; MCF7; HG-U133A | 2.26e-04 | 196 | 35 | 4 | 253_DN | |
| Drug | Evoxine [522-11-2]; Up 200; 11.6uM; PC3; HT_HG-U133A | 2.31e-04 | 197 | 35 | 4 | 3681_UP | |
| Drug | Cefixime [79350-37-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 2.31e-04 | 197 | 35 | 4 | 3247_UP | |
| Drug | Estrone [53-16-7]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 2.31e-04 | 197 | 35 | 4 | 4993_UP | |
| Drug | Fludrocortisone acetate [514-36-3]; Down 200; 9.4uM; PC3; HT_HG-U133A | 2.35e-04 | 198 | 35 | 4 | 3785_DN | |
| Drug | sulindac; Down 200; 50uM; MCF7; HG-U133A | 2.35e-04 | 198 | 35 | 4 | 307_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; PC3; HT_HG-U133A | 2.35e-04 | 198 | 35 | 4 | 4446_UP | |
| Drug | Diphenylpyraline hydrochloride [132-18-3]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 2.35e-04 | 198 | 35 | 4 | 4765_UP | |
| Drug | Benzydamine hydrochloride [132-69-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 2.35e-04 | 198 | 35 | 4 | 7169_DN | |
| Drug | Tocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; PC3; HT_HG-U133A | 2.35e-04 | 198 | 35 | 4 | 6616_UP | |
| Drug | CP-9 | 2.38e-04 | 15 | 35 | 2 | CID000452634 | |
| Drug | haloperidol; Up 200; 10uM; PC3; HT_HG-U133A | 2.40e-04 | 199 | 35 | 4 | 4427_UP | |
| Drug | sulindac sulfone; Down 200; 50uM; MCF7; HG-U133A | 2.40e-04 | 199 | 35 | 4 | 309_DN | |
| Drug | N6,2'-O-Dibutyryladenosine 3',5'-cyclic monophosphate sodium salt; Down 200; 20uM; MCF7; HG-U133A | 2.40e-04 | 199 | 35 | 4 | 591_DN | |
| Drug | Isocarboxazid [59-63-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 2.40e-04 | 199 | 35 | 4 | 3684_DN | |
| Drug | Ciprofibrate [52214-84-3]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 2.40e-04 | 199 | 35 | 4 | 6218_UP | |
| Drug | Saquinavir mesylate [149845-06-7]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 2.44e-04 | 200 | 35 | 4 | 6246_UP | |
| Drug | Rilmenidine hemifumarate [54187-04-1]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 2.44e-04 | 200 | 35 | 4 | 5532_UP | |
| Drug | Canavanine sulfate monohydrate (L,+) [206996-57-8]; Up 200; 13.6uM; HL60; HT_HG-U133A | 2.44e-04 | 200 | 35 | 4 | 2141_UP | |
| Drug | Leuk | 2.72e-04 | 16 | 35 | 2 | CID003043300 | |
| Disease | Hematuria | 5.18e-05 | 9 | 36 | 2 | C0018965 | |
| Disease | collagen disease (implicated_via_orthology) | 9.48e-05 | 12 | 36 | 2 | DOID:854 (implicated_via_orthology) | |
| Disease | aspartate aminotransferase measurement | 9.50e-05 | 904 | 36 | 7 | EFO_0004736 | |
| Disease | parental longevity | 3.17e-04 | 494 | 36 | 5 | EFO_0007796 | |
| Disease | glomerular filtration rate, renal transplant outcome measurement, donor genotype effect measurement | 3.29e-04 | 22 | 36 | 2 | EFO_0005199, EFO_0005208, EFO_0007892 | |
| Disease | sugar consumption measurement | 4.25e-04 | 120 | 36 | 3 | EFO_0010158 | |
| Disease | aggressive behaviour measurement, childhood aggressive behaviour measurement | 7.01e-04 | 32 | 36 | 2 | EFO_0007663, EFO_0007826 | |
| Disease | Focal glomerulosclerosis | 8.88e-04 | 36 | 36 | 2 | C0017668 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TGCVYLSTYTYPWQA | 111 | Q6ZRU5 | |
| DWNTSDYCITPYAYN | 376 | Q9NX77 | |
| GYPGNYFNSQTCSWS | 2336 | Q96PZ7 | |
| SVAYDCLWNYSQYPS | 86 | Q9UIF9 | |
| YTCSSHFPYSQYQFW | 176 | P51681 | |
| SGYSSQWCYENFVQF | 891 | O60231 | |
| TCNYYANAYSFWLAT | 1621 | P02462 | |
| WTQTYDIAFYFSGFC | 456 | Q7RTY1 | |
| YHCYYQSPAGWSEPS | 96 | P59901 | |
| NWICMAYYESGYNTT | 46 | Q6UWQ5 | |
| NWICMAYYESGYNTT | 46 | Q7Z4W2 | |
| DSYDYWCDVNSPYVQ | 231 | Q8NA19 | |
| SYEAASCLYIWNTGY | 86 | P35218 | |
| NYSCRYYDFSIWSEP | 846 | Q8N6C5 | |
| WNYYEGFFYPSCTGS | 371 | Q9P109 | |
| GTCNYYANSYSFWLA | 1636 | P29400 | |
| CNSWEYVYYYCNVNP | 46 | Q30KQ7 | |
| CDQNFVTPSGSYWDY | 56 | Q92496 | |
| YYCDQNFVTPSGSYW | 301 | Q92496 | |
| QGPWSFIYYQASSHY | 116 | Q9NWL6 | |
| FCYPNYLASGAWQSS | 131 | Q3LI77 | |
| PWIPYQYYSGSCENT | 171 | P11047 | |
| YSCSLYTYPQGTWQK | 106 | Q15762 | |
| PEEWITYSNSCYYIG | 121 | O43908 | |
| AVYYECNGQTYWDSN | 211 | Q86XI6 | |
| TWQPYQYYATDCLDA | 171 | Q9Y2I2 | |
| NPNYGYTSYDTFSWA | 381 | P35499 | |
| CYTTQSYQWYSWGPP | 396 | Q13330 | |
| SSDANYPAYYESWNR | 361 | O15047 | |
| PYDWIGFQNKCYYFS | 36 | Q92478 | |
| PLNWEYFQSSCYFFS | 81 | Q9ULY5 | |
| PTYYDNCSFYFWLHT | 486 | P56180 | |
| TSDYKYITCQYGEWF | 281 | Q5VX71 | |
| YITCQYGEWFPSYQV | 286 | Q5VX71 | |
| YGEWFPSYQVYCIKS | 291 | Q5VX71 | |
| NCTYTATGYPSLFWY | 41 | A0A087WT02 | |
| KCNYSYSGSPELFWY | 41 | A0A0A6YYK6 | |
| YDNVSAVYIYNCNSW | 1671 | P21359 | |
| VYGVFSNPWNYSAVC | 321 | O75326 | |
| TWFGYFNSTCNPLIY | 301 | Q9P1P5 | |
| NCSYETTQYPSLFWY | 41 | A0A075B6T8 | |
| KCTYSVSGNPYLFWY | 41 | A0A0B4J244 | |
| LFGTSYPYSAWCVYQ | 2651 | Q9BXT5 | |
| YPYSAWCVYQYSNSN | 2656 | Q9BXT5 | |
| CAYENTAFDYFPWYQ | 51 | A0A075B6W5 | |
| KCTYSDSASNYFPWY | 41 | A0A0B4J241 |